A Common Medication With a Rare Side Effect: A Case Report of Statin-Induced Necrotizing Autoimmune Myopathy
Recommended Citation
Grossmann M, Drallmeier M, Jin M, and Scher E. A Common Medication With a Rare Side Effect: A Case Report of Statin-Induced Necrotizing Autoimmune Myopathy. Cureus 2025;17(5):e83589.
Document Type
Article
Publication Date
5-1-2025
Publication Title
Cureus
Keywords
adverse drug reaction; anti-hmg-coa reductase antibody; anti-signal recognition particle antibody; myopathy; statin-induced necrotizing autoimmune myopathy; statins
Abstract
Statins are commonly used for their cholesterol-lowering properties and are prescribed for primary and secondary prevention of cardiovascular disease. Although they are generally well tolerated, some individuals may experience a rare and serious side effect in which autoantibodies develop and lead to a necrotizing myopathy. Here we present a case of a middle-aged woman chronically on atorvastatin for her hyperlipidemia who acutely developed myalgias, muscle weakness, and persistently elevated creatine kinase, who was eventually diagnosed with statin-induced necrotizing autoimmune myopathy.
PubMed ID
40476112
Volume
17
Issue
5
First Page
83589
Last Page
83589
